1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Oral 1.2.3 Subcutaneous Injection 1.2.4 Others 1.3 Market by Application 1.3.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Perspective (2018-2029) 2.2 Hereditary Transthyretin Amyloidosis (HATTR) Growth Trends by Region 2.2.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Hereditary Transthyretin Amyloidosis (HATTR) Historic Market Size by Region (2018-2023) 2.2.3 Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Region (2024-2029) 2.3 Hereditary Transthyretin Amyloidosis (HATTR) Market Dynamics 2.3.1 Hereditary Transthyretin Amyloidosis (HATTR) Industry Trends 2.3.2 Hereditary Transthyretin Amyloidosis (HATTR) Market Drivers 2.3.3 Hereditary Transthyretin Amyloidosis (HATTR) Market Challenges 2.3.4 Hereditary Transthyretin Amyloidosis (HATTR) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hereditary Transthyretin Amyloidosis (HATTR) Players by Revenue 3.1.1 Global Top Hereditary Transthyretin Amyloidosis (HATTR) Players by Revenue (2018-2023) 3.1.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Players (2018-2023) 3.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Hereditary Transthyretin Amyloidosis (HATTR) Revenue 3.4 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Concentration Ratio 3.4.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hereditary Transthyretin Amyloidosis (HATTR) Revenue in 2022 3.5 Hereditary Transthyretin Amyloidosis (HATTR) Key Players Head office and Area Served 3.6 Key Players Hereditary Transthyretin Amyloidosis (HATTR) Product Solution and Service 3.7 Date of Enter into Hereditary Transthyretin Amyloidosis (HATTR) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hereditary Transthyretin Amyloidosis (HATTR) Breakdown Data by Type 4.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Historic Market Size by Type (2018-2023) 4.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Type (2024-2029) 5 Hereditary Transthyretin Amyloidosis (HATTR) Breakdown Data by Application 5.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Historic Market Size by Application (2018-2023) 5.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2018-2029) 6.2 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2018-2023) 6.4 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2018-2029) 7.2 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2018-2023) 7.4 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2018-2029) 8.2 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2018-2023) 8.4 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2018-2029) 9.2 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2018-2023) 9.4 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2018-2029) 10.2 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2018-2023) 10.4 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Detail 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Introduction 11.1.4 Pfizer Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2018-2023) 11.1.5 Pfizer Recent Development 11.2 Alnylam Pharmaceuticals 11.2.1 Alnylam Pharmaceuticals Company Detail 11.2.2 Alnylam Pharmaceuticals Business Overview 11.2.3 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Introduction 11.2.4 Alnylam Pharmaceuticals Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2018-2023) 11.2.5 Alnylam Pharmaceuticals Recent Development 11.3 Akcea Therapeutics 11.3.1 Akcea Therapeutics Company Detail 11.3.2 Akcea Therapeutics Business Overview 11.3.3 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Introduction 11.3.4 Akcea Therapeutics Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2018-2023) 11.3.5 Akcea Therapeutics Recent Development 11.4 Prothena 11.4.1 Prothena Company Detail 11.4.2 Prothena Business Overview 11.4.3 Prothena Hereditary Transthyretin Amyloidosis (HATTR) Introduction 11.4.4 Prothena Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2018-2023) 11.4.5 Prothena Recent Development 11.5 Lonis Pharmaceuticals 11.5.1 Lonis Pharmaceuticals Company Detail 11.5.2 Lonis Pharmaceuticals Business Overview 11.5.3 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Introduction 11.5.4 Lonis Pharmaceuticals Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2018-2023) 11.5.5 Lonis Pharmaceuticals Recent Development 11.6 Eidos Therapeutics 11.6.1 Eidos Therapeutics Company Detail 11.6.2 Eidos Therapeutics Business Overview 11.6.3 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Introduction 11.6.4 Eidos Therapeutics Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2018-2023) 11.6.5 Eidos Therapeutics Recent Development 11.7 Corino Therapeutics Inc 11.7.1 Corino Therapeutics Inc Company Detail 11.7.2 Corino Therapeutics Inc Business Overview 11.7.3 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Introduction 11.7.4 Corino Therapeutics Inc Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2018-2023) 11.7.5 Corino Therapeutics Inc Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Oral Table 3. Key Players of Subcutaneous Injection Table 4. Key Players of Others Table 5. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 6. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 7. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2018-2023) & (US$ Million) Table 8. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Region (2018-2023) Table 9. Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 10. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Region (2024-2029) Table 11. Hereditary Transthyretin Amyloidosis (HATTR) Market Trends Table 12. Hereditary Transthyretin Amyloidosis (HATTR) Market Drivers Table 13. Hereditary Transthyretin Amyloidosis (HATTR) Market Challenges Table 14. Hereditary Transthyretin Amyloidosis (HATTR) Market Restraints Table 15. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue by Players (2018-2023) & (US$ Million) Table 16. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Players (2018-2023) Table 17. Global Top Hereditary Transthyretin Amyloidosis (HATTR) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Transthyretin Amyloidosis (HATTR) as of 2022) Table 18. Ranking of Global Top Hereditary Transthyretin Amyloidosis (HATTR) Companies by Revenue (US$ Million) in 2022 Table 19. Global 5 Largest Players Market Share by Hereditary Transthyretin Amyloidosis (HATTR) Revenue (CR5 and HHI) & (2018-2023) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Hereditary Transthyretin Amyloidosis (HATTR) Product Solution and Service Table 22. Date of Enter into Hereditary Transthyretin Amyloidosis (HATTR) Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2018-2023) & (US$ Million) Table 25. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Type (2018-2023) Table 26. Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 27. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Type (2024-2029) Table 28. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2018-2023) & (US$ Million) Table 29. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Application (2018-2023) Table 30. Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 31. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Application (2024-2029) Table 32. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 33. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2018-2023) & (US$ Million) Table 34. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2024-2029) & (US$ Million) Table 35. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 36. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2018-2023) & (US$ Million) Table 37. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2024-2029) & (US$ Million) Table 38. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 39. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2018-2023) & (US$ Million) Table 40. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2024-2029) & (US$ Million) Table 41. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 42. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2018-2023) & (US$ Million) Table 43. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2024-2029) & (US$ Million) Table 44. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 45. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2018-2023) & (US$ Million) Table 46. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2024-2029) & (US$ Million) Table 47. Pfizer Company Detail Table 48. Pfizer Business Overview Table 49. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Product Table 50. Pfizer Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2018-2023) & (US$ Million) Table 51. Pfizer Recent Development Table 52. Alnylam Pharmaceuticals Company Detail Table 53. Alnylam Pharmaceuticals Business Overview Table 54. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product Table 55. Alnylam Pharmaceuticals Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2018-2023) & (US$ Million) Table 56. Alnylam Pharmaceuticals Recent Development Table 57. Akcea Therapeutics Company Detail Table 58. Akcea Therapeutics Business Overview Table 59. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product Table 60. Akcea Therapeutics Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2018-2023) & (US$ Million) Table 61. Akcea Therapeutics Recent Development Table 62. Prothena Company Detail Table 63. Prothena Business Overview Table 64. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Product Table 65. Prothena Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2018-2023) & (US$ Million) Table 66. Prothena Recent Development Table 67. Lonis Pharmaceuticals Company Detail Table 68. Lonis Pharmaceuticals Business Overview Table 69. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product Table 70. Lonis Pharmaceuticals Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2018-2023) & (US$ Million) Table 71. Lonis Pharmaceuticals Recent Development Table 72. Eidos Therapeutics Company Detail Table 73. Eidos Therapeutics Business Overview Table 74. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product Table 75. Eidos Therapeutics Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2018-2023) & (US$ Million) Table 76. Eidos Therapeutics Recent Development Table 77. Corino Therapeutics Inc Company Detail Table 78. Corino Therapeutics Inc Business Overview Table 79. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Product Table 80. Corino Therapeutics Inc Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2018-2023) & (US$ Million) Table 81. Corino Therapeutics Inc Recent Development Table 82. Research Programs/Design for This Report Table 83. Key Data Information from Secondary Sources Table 84. Key Data Information from Primary Sources List of Figures Figure 1. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Type: 2022 VS 2029 Figure 3. Oral Features Figure 4. Subcutaneous Injection Features Figure 5. Others Features Figure 6. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 7. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Application: 2022 VS 2029 Figure 8. Hospital Case Studies Figure 9. Clinic Case Studies Figure 10. Others Case Studies Figure 11. Hereditary Transthyretin Amyloidosis (HATTR) Report Years Considered Figure 12. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 13. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 14. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Region: 2022 VS 2029 Figure 15. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Players in 2022 Figure 16. Global Top Hereditary Transthyretin Amyloidosis (HATTR) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Transthyretin Amyloidosis (HATTR) as of 2022) Figure 17. The Top 10 and 5 Players Market Share by Hereditary Transthyretin Amyloidosis (HATTR) Revenue in 2022 Figure 18. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 19. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Country (2018-2029) Figure 20. United States Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 21. Canada Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 22. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 23. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Country (2018-2029) Figure 24. Germany Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 25. France Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. U.K. Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. Italy Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. Russia Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Nordic Countries Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Region (2018-2029) Figure 32. China Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 33. Japan Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. South Korea Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. Southeast Asia Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. India Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. Australia Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Country (2018-2029) Figure 40. Mexico Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. Brazil Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Country (2018-2029) Figure 44. Turkey Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 45. Saudi Arabia Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 46. Pfizer Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2018-2023) Figure 47. Alnylam Pharmaceuticals Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2018-2023) Figure 48. Akcea Therapeutics Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2018-2023) Figure 49. Prothena Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2018-2023) Figure 50. Lonis Pharmaceuticals Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2018-2023) Figure 51. Eidos Therapeutics Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2018-2023) Figure 52. Corino Therapeutics Inc Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2018-2023) Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

Pfizer Alnylam Pharmaceuticals Akcea Therapeutics Prothena Lonis Pharmaceuticals Eidos Therapeutics Corino Therapeutics Inc